PortViewPortView
Alcon logo

Alcon (ALC) Stock Analysis

NYSEHealthcareMedical - Specialties

$69.58+0.23%
1-year price historyRange $62.02 – $87.18
52-week range$69.58
$61.84$87.64

Track ALC in your portfolio for free · Portfolio tracker

What Alcon does

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Key metrics

Market cap
$33.63B
P/E (TTM)
21.88
EPS (TTM)
$3.18
Beta
0.73
Dividend yield
0.52%
Revenue / share
$22.21
50-day avg
$67.81
200-day avg
$72.09
52-week high
$87.64
52-week low
$61.84
CEO
David J. Endicott

ETFs linked to ALC

Broad-market and Healthcare sector ETFs an investor holding Alcon is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ALC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALC in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Alcon?
Alcon trades under the ticker ALC on NYSE.
Which exchange is ALC listed on?
ALC is listed on NYSE.
What sector does Alcon operate in?
Alcon is classified in the Healthcare sector (Medical - Specialties industry).
How can PortView help analyze ALC in a portfolio?
PortView shows ALC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.